Market Overview:
The global in vitro lung model market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for in vitro lung models for drug discovery and toxicology, physiological research, stem cell research and regenerative medicine applications. Additionally, the growing prevalence of respiratory diseases is also contributing to the growth of the market. However, high costs associated with these models are restraining their adoption in certain regions. On the basis of type, 2D models accounted for a major share of the global in vitro lung model market in 2017. This can be attributed to their low cost and easy availability as compared to 3D models.
Product Definition:
A lung model is a three-dimensional (3D) in vitro model that mimics the functional and histological features of an intact lung. In vitro models are useful for studying the pathophysiology of diseases, drug efficacy and toxicity, and the mechanisms of airway remodeling.
2D Models:
2D models are used in the process of drug designing and development. It is also used for research purposes, preclinical testing, clinical trials and other stages of drug discovery. The factors that propel its usage include growing demand for personalized medicines by healthcare professionals and patients coupled with increasing investments in R&D by pharmaceutical companies to develop drugs with novel mechanisms of action.
3D Models:
3D models are used in the process of In Vitro Lung (IVL) testing. It is a technique that involves creating a replica of the organ using various types of software programs and then testing it to determine how effective the drug is in improving lung function. The 3D model helps researchers test new drugs for COPD at an early stage when other tests fail, which significantly reduces experimental costs as well as animal suffering.
Application Insights:
The drug discovery and toxicology segment dominated the global in vitro lung model market, accounting for a revenue share of over 30.0% in 2017. The key factors contributing to this growth include extensive usage of 3D models for screening of various compounds at the cellular level as well as molecular level. Moreover, an increase in toxicity studies on drugs with respiratory applications is also expected to contribute significantly towards segment growth during the forecast period.
The physiological research segment is expected to witness significant growth during the forecast period due to rising demand from educational institutions and healthcare professionals for conducting complex experiments involving human lungs at a lower cost than conventional alternatives such as animal models or cell lines derived from humans¢â‚¬â„¢ skin cells¢â‚¬ which are used by researchers worldwide owing to their high costs and limited availability due to ethical issues involved therewith.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, increased funding for research activities, and high demand for new drug development. The U.S.-based companies are engaged in extensive R&D activities to develop novel therapeutics and vaccines against COVID-19 that is expected to propel growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing government initiatives pertaining Lung Research Foundation International (LRFI)’s annual conference held last month in Singapore focused on the role of lungs & airway biology in disease progression and host defense mechanisms across a broad range of diseases from COPD through asthma & other allergic disorders, lung cancer & infections to obesity-related respiratory diseases such as chronic obstructive pulmonary disease (COPD).
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing every year. This is mainly due to the changing lifestyle and environmental conditions. In Vitro Lung Model market is expected to grow significantly as it helps in the diagnosis and treatment of various respiratory diseases.
- Growing demand for personalized medicine: With the advent of precision medicine, there is an increasing demand for customized medical treatments. In Vitro Lung Model market offers great potential as it helps in the development of personalized medicines for treating various respiratory disorders.
- Technological advancements: The field of lung biology is rapidly evolving with many new technological advancements being made every day. In Vitro Lung Model market has a huge potential to grow as it enables researchers to study complex lung functions and develop better therapies for respiratory disorders .
Scope Of The Report
Report Attributes
Report Details
Report Title
In Vitro Lung Model Market Research Report
By Type
2D Models, 3D Models
By Application
Drug Discovery and Toxicology, Physiological Research, Stem Cell Research and Regenerative Medicine
By Companies
Atcc, Lonza, Epithelix, Mattek, Emulate, Tissuse, Mimetas, Insphero, Cn Bio Innovations, Atcc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global In Vitro Lung Model Market Report Segments:
The global In Vitro Lung Model market is segmented on the basis of:
Types
2D Models, 3D Models
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Discovery and Toxicology, Physiological Research, Stem Cell Research and Regenerative Medicine
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Atcc
- Lonza
- Epithelix
- Mattek
- Emulate
- Tissuse
- Mimetas
- Insphero
- Cn Bio Innovations
- Atcc
Highlights of The In Vitro Lung Model Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2D Models
- 3D Models
- By Application:
- Drug Discovery and Toxicology
- Physiological Research
- Stem Cell Research and Regenerative Medicine
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Vitro Lung Model Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The In Vitro Lung Model is a research tool that allows scientists to study the effects of various treatments on lung cells in a controlled environment.
Some of the major players in the in vitro lung model market are Atcc, Lonza, Epithelix, Mattek, Emulate, Tissuse, Mimetas, Insphero, Cn Bio Innovations, Atcc.
The in vitro lung model market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In Vitro Lung Model Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 In Vitro Lung Model Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 In Vitro Lung Model Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the In Vitro Lung Model Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global In Vitro Lung Model Market Size & Forecast, 2018-2028
4.5.1 In Vitro Lung Model Market Size and Y-o-Y Growth
4.5.2 In Vitro Lung Model Market Absolute $ Opportunity
Chapter 5 Global In Vitro Lung Model Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 In Vitro Lung Model Market Size Forecast by Type
5.2.1 2D Models
5.2.2 3D Models
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global In Vitro Lung Model Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 In Vitro Lung Model Market Size Forecast by Applications
6.2.1 Drug Discovery and Toxicology
6.2.2 Physiological Research
6.2.3 Stem Cell Research and Regenerative Medicine
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In Vitro Lung Model Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In Vitro Lung Model Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America In Vitro Lung Model Analysis and Forecast
9.1 Introduction
9.2 North America In Vitro Lung Model Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America In Vitro Lung Model Market Size Forecast by Type
9.6.1 2D Models
9.6.2 3D Models
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America In Vitro Lung Model Market Size Forecast by Applications
9.10.1 Drug Discovery and Toxicology
9.10.2 Physiological Research
9.10.3 Stem Cell Research and Regenerative Medicine
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe In Vitro Lung Model Analysis and Forecast
10.1 Introduction
10.2 Europe In Vitro Lung Model Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe In Vitro Lung Model Market Size Forecast by Type
10.6.1 2D Models
10.6.2 3D Models
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe In Vitro Lung Model Market Size Forecast by Applications
10.10.1 Drug Discovery and Toxicology
10.10.2 Physiological Research
10.10.3 Stem Cell Research and Regenerative Medicine
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific In Vitro Lung Model Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific In Vitro Lung Model Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific In Vitro Lung Model Market Size Forecast by Type
11.6.1 2D Models
11.6.2 3D Models
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific In Vitro Lung Model Market Size Forecast by Applications
11.10.1 Drug Discovery and Toxicology
11.10.2 Physiological Research
11.10.3 Stem Cell Research and Regenerative Medicine
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America In Vitro Lung Model Analysis and Forecast
12.1 Introduction
12.2 Latin America In Vitro Lung Model Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America In Vitro Lung Model Market Size Forecast by Type
12.6.1 2D Models
12.6.2 3D Models
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America In Vitro Lung Model Market Size Forecast by Applications
12.10.1 Drug Discovery and Toxicology
12.10.2 Physiological Research
12.10.3 Stem Cell Research and Regenerative Medicine
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) In Vitro Lung Model Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) In Vitro Lung Model Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) In Vitro Lung Model Market Size Forecast by Type
13.6.1 2D Models
13.6.2 3D Models
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) In Vitro Lung Model Market Size Forecast by Applications
13.10.1 Drug Discovery and Toxicology
13.10.2 Physiological Research
13.10.3 Stem Cell Research and Regenerative Medicine
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In Vitro Lung Model Market: Competitive Dashboard
14.2 Global In Vitro Lung Model Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Atcc
14.3.2 Lonza
14.3.3 Epithelix
14.3.4 Mattek
14.3.5 Emulate
14.3.6 Tissuse
14.3.7 Mimetas
14.3.8 Insphero
14.3.9 Cn Bio Innovations
14.3.10 Atcc
